Christine Desmedt is Assistant Professor at the Katholieke Universiteit Leuven (KU Leuven), where she is heading the Laboratory for Translational Breast Cancer Research since October 2018. Before, she was working in the J.-C. Heuson Breast Cancer Translational Laboratory (BCTL) at the Institut Jules Bordet, Université Libre de Bruxelles, Brussels. During the past years, she made significant contributions to the characterization of breast cancer molecular heterogeneity from the perspective of inter-patient and intra-patient variability, first using mainly gene expression profiling and then massive parallel sequencing. She also focuses on rarer BC subtypes such as lobular and mucinous breast tumours. In this context, C. Desmedt is a co-founder of the European lobular BC consortium to further advance research for this disease entity by involving many institutions and disciplines (www.elbcc.org). Finally, C. Desmedt developed, together with key collaborators, a translational research axis on breast cancer and obesity. C. Desmedt has received grants from the Belgian and Luxemburg Cancer Foundation, CELSA, and the FWO.